25 related articles for article (PubMed ID: 38469634)
1. Relationship between menopausal hormone therapy and colorectal cancer: a cohort study utilizing the health insurance database in South Korea (HISK)-II.
Yuk JS; Noh JH; Kim MH; Han GH; Kim J; Cho H; Gwak G; Lee Y
Menopause; 2024 Jun; ():. PubMed ID: 38860931
[TBL] [Abstract][Full Text] [Related]
2. Menopausal hormone therapy decreases the likelihood of diabetes development in peri‑menopausal individuals with prediabetes.
Shih YH; Yang CY; Wang SJ; Lung CC
Diabetes Metab; 2024 Jun; 50(4):101546. PubMed ID: 38843591
[TBL] [Abstract][Full Text] [Related]
3. Progestogen in menopausal hormone therapy and breast cancer risk.
Yuk JS
Obstet Gynecol Sci; 2024 May; 67(3):339-340. PubMed ID: 38584426
[No Abstract] [Full Text] [Related]
4. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim T; Cho H; Gwak G
Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy increases the risk of gallstones: Health Insurance Database in South Korea (HISK)-based cohort study.
Yuk JS; Park JY
PLoS One; 2023; 18(12):e0294356. PubMed ID: 38048308
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy with conjugated equine estrogen is associated with a higher risk of hemorrhagic stroke than therapy with estradiol: a retrospective population-based cohort study.
Chang WC; Wang JH; Ding DC
Maturitas; 2022 Nov; 165():72-77. PubMed ID: 35933795
[TBL] [Abstract][Full Text] [Related]
7. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy and risk of dementia: health insurance database in South Korea-based retrospective cohort study.
Yuk JS; Lee JS; Park JH
Front Aging Neurosci; 2023; 15():1213481. PubMed ID: 37744387
[TBL] [Abstract][Full Text] [Related]
9. Relationship between menopausal hormone therapy and breast cancer: A nationwide population-based cohort study.
Yuk JS
Int J Gynaecol Obstet; 2024 Mar; ():. PubMed ID: 38469634
[TBL] [Abstract][Full Text] [Related]
10. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
L'Hermite M
Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and breast cancer risk.
Rozenberg S; Di Pietrantonio V; Vandromme J; Gilles C
Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101577. PubMed ID: 34535397
[TBL] [Abstract][Full Text] [Related]
12. Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins.
Graham S; Archer DF; Simon JA; Ohleth KM; Bernick B
Gynecol Endocrinol; 2022 Nov; 38(11):891-910. PubMed ID: 36075250
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
